Why Premier Biotech’s NexScreen and TransMed acquisitions could reshape rapid drug testing
Discover how Premier Biotech’s NexScreen and TransMed acquisitions expand point-of-care testing, e-commerce and global diagnostics reach.
Discover how Premier Biotech’s NexScreen and TransMed acquisitions expand point-of-care testing, e-commerce and global diagnostics reach.
Find out how USDTL’s integration with CourtFact could reshape digital drug testing workflows for justice-involved programs.